Trastuzumab deruxtecan: expanding the role of HER2-targeted therapy in solid tumors.

ABSTRACT:

SUBMITTER: Aboaid H 

PROVIDER: S-EPMC12268644 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature